Chen Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chen Yang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bocheng Xu
MOE Key Laboratory of Macromolecule Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, PR China
1 shared publication Lin Wang
National Engineering Research Center for Green Feed and Healthy Breeding, Key Laboratory of Molecular Animal Nutrition, Ministry of Education, Key Laboratory of Animal Nutrition and Feed Science (Eastern of China), Ministry of Agriculture and Rural Affairs, Key Laboratory of Animal Feed and Nutrition of Zhejiang Province, Institute of Feed Science, Zhejiang University, Hangzhou 310058, China
1 shared publication- Mingliang Jin
Zhejiang University
1 shared publication - Pan Zhang
College of Animal Science, Zhejiang University; Hangzhou 310058, China
1 shared publication - Rong Yan
National Engineering Research Center for Green Feed and Healthy Breeding, Key Laboratory of Molecular Animal Nutrition, Ministry of Education, Key Laboratory of Animal Nutrition and Feed Science (Eastern of China), Ministry of Agriculture and Rural Affairs, Key Laboratory of Animal Feed and Nutrition of Zhejiang Province, Institute of Feed Science, Zhejiang University, Hangzhou 310058, China
1 shared publication - Tingjun Chen
Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
1 shared publication
Latest Publications
- Open Access
- 29 September 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (39) , eadf8782
Gut-targeted nanoparticles deliver specifically targeted antimicrobial peptides against Clostridium perfringens infections
Specifically targeted antimicrobial peptides (STAMPs) are novel alternatives to antibiotics, whereas the development of STAMPs for colonic infections is hindered by limited de novo design efficiency and colonic bioavailability. In this study, we report an efficient de novo STAMP design strategy that combines a traversal design, machine learning model, and phage display technology to identify STAMPs against Clostridium perfringens . STAMPs could physically damage C. perfringens , eliminate biofilms, and self-assemble into nanoparticles to entrap pathogens. Further, a gut-targeted engineering particle vaccine (EPV) was used for STAMPs delivery. In vivo studies showed that both STAMP and EPV@STAMP effectively limited C. perfringens infections and then reduced inflammatory response. Notably, EPV@STAMP exhibited stronger protection against colonic infections than STAMPs alone. Moreover, 16 S ribosomal RNA sequencing showed that both STAMPs and EPV@STAMP facilitated the recovery of disturbed gut microflora. Collectively, our work may accelerate the development of the discovery and delivery of precise antimicrobials.
- 29 September 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (39) , eadf8782
Open AccessGut-targeted nanoparticles deliver specifically targeted antimicrobial peptides against Clostridium perfringens infections
Specifically targeted antimicrobial peptides (STAMPs) are novel alternatives to antibiotics, whereas the development of STAMPs for colonic infections is hindered by limited de novo design efficiency and colonic bioavailability. In this study, we report an efficient de novo STAMP design strategy that combines a traversal design, machine learning model, and phage display technology to identify STAMPs against Clostridium perfringens . STAMPs could physically damage C. perfringens , eliminate biofilms, and self-assemble into nanoparticles to entrap pathogens. Further, a gut-targeted engineering particle vaccine (EPV) was used for STAMPs delivery. In vivo studies showed that both STAMP and EPV@STAMP effectively limited C. perfringens infections and then reduced inflammatory response. Notably, EPV@STAMP exhibited stronger protection against colonic infections than STAMPs alone. Moreover, 16 S ribosomal RNA sequencing showed that both STAMPs and EPV@STAMP facilitated the recovery of disturbed gut microflora. Collectively, our work may accelerate the development of the discovery and delivery of precise antimicrobials.